Processa Pharmaceuticals, Inc. (PCSA) Gross margin 2012–2016
Processa Pharmaceuticals, Inc. (PCSA) gross margin by fiscal year — reported gross profit divided by reported revenue.
100.0%FY2016 · since FY2012: 30.6% → 100.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2016 | 100.0% | +111.0 pp |
| FY2015 | -11.0% | -48.7 pp |
| FY2014 | 37.7% | -2.2 pp |
| FY2013 | 39.8% | +9.2 pp |
| FY2012 | 30.6% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice